Integra LifeSciences debuts Camino Platform at AANS


Integra is a provider of advanced intracranial pressure monitoring systems. Over 800 centres, according to a company release, in the USA use the Camino platform for conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid haemorrhage, and stroke.

The new Camino platform includes the Integra Camino Intracranial Pressure and Temperature Monitor and Integra Camino Flex Ventricular Catheter. Both products have received 510(k) clearance from the US Food and Drug Administration (FDA), and were featured at the American Association of Neurological Surgeons Annual Scientific Meeting (AANS), 27 April–1 May 2013, in New Orleans, USA.

Peter Ligotti, Integra’s vice president of Marketing, Neurosurgery said: “Our Camino monitor has been completely updated and modernised, making it easier to use. It also offers our customers convenient options for utilising both our current Camino fibre optic catheter technology, as well as the newest addition to the family, the Camino ventricular catheter, which utilises strain gauge technology.”

According to the company, unlike other tunnelled ventricular catheters that depend upon cerebrospinal fluid flow to measure intracranial pressure, Integra’s Camino Flex Ventricular Catheter continuously monitors intracranial pressure independently in the ventricles, even when cerebrospinal fluid flow cannot be established. A multilumen design also allows for simultaneous cerebrospinal fluid drainage and intracranial pressure monitoring, providing uninterrupted measurement of patient pressure.